Pasithea Therapeutics Corp. · NASDAQ:KTTA

Squadron Capital Management LLC reported a 9.90% stake in Pasithea Therapeutics Corp. (Schedule 13G)

Event Nov 28, 2025 · Filed Dec 5, 2025

Squadron Capital Management LLC reported a 9.90% stake in Pasithea Therapeutics Corp., 2,252,930 shares, as a passive investor on Nov 28, 2025. Filed Dec 5, 2025 (Schedule 13G).

Stake
9.90%
Shares
2,252,930
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Squadron Master Fund LP7.30%1,649,790
Squadron Capital Management LLC9.90%2,252,930
Matthew Sesterhenn9.90%2,252,930
William Blank9.90%2,252,930

Source

View original at SEC

Related